Stocks
BioMarin Pharmaceutical (BMRN) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | ||||
| R&D/CAPEX, % | 527.4% | 537.0% | 493.8% | 694.0% | 281.4% | ||||
| Changes by years, y/y, % | +71pp | -527pp | -43pp | +200pp | +7.6% | ||||
BioMarin Pharmaceutical. R&D/CAPEX, %
BioMarin Pharmaceutical. R&D/CAPEX, changes, pp
BioMarin Pharmaceutical (BMRN) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2024Q1 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
| R&D/CAPEX, % | 601.1% | 841.6% | 280.8% | 873.2% | 281.4% | |||
| Changes by years, y/y, % | -694pp | -93pp | +61pp | -536pp | +56pp | |||
| Changes by quarters, q/q, % | -562pp | +240pp | -561pp | +592pp | ||||
